Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. [electronic resource]
Producer: 20040921Description: 547-53 p. digitalISSN:- 0735-1097
- Abciximab
- Aged
- Anemia -- complications
- Angioplasty, Balloon, Coronary -- adverse effects
- Antibodies, Monoclonal -- therapeutic use
- Blood Component Transfusion -- statistics & numerical data
- Female
- Hematocrit
- Hemorrhage -- etiology
- Hospital Mortality
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Incidence
- Male
- Middle Aged
- Multivariate Analysis
- Myocardial Infarction -- complications
- Platelet Aggregation Inhibitors -- therapeutic use
- Predictive Value of Tests
- Prognosis
- Randomized Controlled Trials as Topic
- Stents -- adverse effects
- Stroke -- etiology
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.